New Approaches to Arrhythmia Detection and Treatment (SBIR [R43/R44])
The summary for the New Approaches to Arrhythmia Detection and Treatment (SBIR [R43/R44]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
New Approaches to Arrhythmia Detection and Treatment (SBIR [R43/R44]): Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to improve our ability to detect, prevent, and treat all forms of cardiac arrhythmias. This initiative encourages SBCs to develop improved diagnostic and therapeutic tools, products, or devices for cardiac arrhythmia monitoring, detection and treatment. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-118, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
Federal Grant Title: | New Approaches to Arrhythmia Detection and Treatment (SBIR [R43/R44]) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-10-117 |
Type of Funding: | Grant |
CFDA Numbers: | 93.837 |
CFDA Descriptions: | Heart and Vascular Diseases Research |
Current Application Deadline: | Jan 07, 2013 |
Original Application Deadline: | Jan 07, 2013 |
Posted Date: | Mar 03, 2010 |
Creation Date: | Mar 03, 2010 |
Archive Date: | Feb 07, 2013 |
Total Program Funding: | |
Maximum Federal Grant Award: | $200,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not...
- • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...
- • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...
- • ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial No...
- • The Relationship Between Hypertension and Inflammation
- • Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...
- • Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)